PTCT · NASDAQ · Biotechnology

PTC Therapeutics (PTCT)

Develops rare-disease medicines spanning PKU, DMD, gene therapy, and RNA-splicing programs.

$65.96
After hours+0.01 (+0.02%)
At close$65.95(+1.06%)